Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 2/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.51 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.51 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.51 |
| ▸ | ECE1 | P42892 | 9/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7994217 | 1.00 | MAPK1 (0.55) | MAPK1SMN1; SMN2ACEERAP2ERAP1 | |
| SCHEMBL8807886 | 1.00 | MAPK1 (0.55) | MAPK1SMN1; SMN2ACEERAP2ERAP1 | |
| SCHEMBL7993541 | 0.98 | MAPK1 (0.54) | MAPK1SMN1; SMN2ACEECE1 | |
| SCHEMBL7990831 | 0.96 | ACE (0.52) | MAPK1SMN1; SMN2ACEERAP2ERAP1 | |
| SCHEMBL7990860 | 0.95 | MAPK1 (0.56) | MAPK1SMN1; SMN2ACEECE1 | |
| SCHEMBL7990814 | 0.92 | MAPK1 (0.53) | MAPK1SMN1; SMN2 | |
| SCHEMBL7987502 | 0.92 | MAPK1 (0.58) | MAPK1SMN1; SMN2ACEECE1 | |
| SCHEMBL7990236 | 0.91 | MAPK1 (0.53) | MAPK1SMN1; SMN2ERAP2ERAP1 | |
| SCHEMBL7976001 | 0.90 | ERAP2 (0.56) | MAPK1SMN1; SMN2ERAP2ERAP1LNPEP | |
| SCHEMBL7987378 | 0.90 | MAPK1 (0.53) | MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207686-B1 | FOR THERAPY OF HYPERTENSION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| WO-1996015109-A1 | ENDOTHELIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-23 | — | — | WO | disclosed |